V

Verastem
D

VSTM

10.880
USD
0.32
(2.98%)
مفتوح الان
حجم التداول
18,135
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
673,920,707
أصول ذات صلة
A
ARRY
-0.11000
(-1.21%)
8.97000 USD
C
CRSP
2.150
(4.08%)
54.870 USD
EXEL
EXEL
0.520
(1.39%)
37.900 USD
INCY
INCY
1.220
(1.43%)
86.650 USD
المزيد
الأخبار المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.